Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens

American Journal of Pathology

Volumn 149, Issue 4, 1996, Pages 1193-1199

  Qian, Junqi ^a   Bostwick, David G ^a   Takahashi, Satoru ^a   Borell, Thomas J ^a   Brown, James A ^a   Lieber, Michael M ^a   Jenkins, Robert B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL NUCLEUS; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 7; CHROMOSOME 8; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; TETRASOMY;

EID: 0029822924     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, Chung LW, Liang JC: Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosomes & Cancer 1994, 9:19-27
2. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB: Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization. Cancer Res 1994, 54:3574-3579
3. o) prostate carcinoma. Clin Cancer Res 1996, 2:137-145
4. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh E, Larson-Keller J, Lieber MM, Jenkins RB: Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 1994, 54: 3998-4002
5. Alers CA, Krijtenburg PJ, Vissers KJ, Bosman FT, van der kwast TH, Dekken H: Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosomes & Cancer 1995, 12:241-250
6. Qian J, Jenkins RB, Bostwick DG: Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate. Urology 1995, 46:837-842
7. Kallioniemi OP, Visakorpi T, Holli K, Heikkinen A, Isola J, Koivula T: Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinoma after correcting for nuclear slicing. Cytometry 1991, 12:413-421
8. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, Jenkins RB: Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995, 55:5408-5414
9. Bostwick DG, Brawer MK: Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 1987, 59:788-794
10. Bostwick DG, Qian J: Atypical adenomatous hyperplasia of the prostate: relationship with carcinoma in 217 whole mount radical prostatectomies. Am J Surg Pathol 1995, 19:506-518
11. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Linehan WM: Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995, 55:2959-2962
12. Lieber MM, Murtaugh PA, Farrow GM, Myers RP, Zincke H: DNA ploidy and surgically treated prostate cancer: important independent association with prognosis for patients with prostate carcinoma treated by radical prostatectomy. Cancer 1995, 75: 1935-1943
13. Shackney SE, Smith CA, Miller BW, Burhdt DR, Murtha K, Giles HR, Ketterer DM, Police AA: Model for the genetic evolution of human solid tumors. Cancer Res 1989, 49:3344-3354
14. Thompson CT, LeBoit PE, Nederlof PM, Gray JW: Thick section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile. Am J Pathol 1994, 144:237-243